SpecialtiesQuestion

Would you treat a completely resected Stage IA NSCLC EGFR exon 19 with adjuvant osimertinib alone omitting chemotherapy?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

Would you offer empiric lung SBRT for two growing FDG-avid lung lesions in a patient with severe COPD on oxygen?

Are you using maintenance lurbinectedin with immunotherapy in the first-line treatment of extensive stage small cell lung cancer?

How would you approach adjuvant therapy for patients with mucinous lung adenocarcinoma with an intestinal phenotype?

Would you recommend adjuvant immunotherapy after platinum-based chemotherapy for patients with in resected NSCLC with HER2 mutations?

How do you choose between Ipilimumab/Nivolumab (Checkmate 9LA) vs Durvalumab/Tremelimumab (POSEIDON) with chemotherapy in first line for mNSCLC with high PDL1, KEAP, and/or STK11 mutations?

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.